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Abstract
Multiscale simulations are essential in the biomedical domain to ac-
curately model human physiology. We present a modular approach for
designing, constructing and executing multiscale simulations on a wide
range of resources, from desktops to petascale supercomputers, including
combinations of these. Our work features two multiscale applications, in-
stent restenosis and cerebrovascular bloodflow, which combine multiple
existing single-scale applications to create a multiscale simulation. These
applications can be efficiently coupled, deployed and executed on comput-
ers up to the largest (peta) scale, incurring a coupling overhead of 1 to
10% of the total execution time.
1 Introduction
Models of biomedical systems are inherently complex; properties on small time
and length scales, such as the molecular or genome level, can make a substantial
difference to the properties observed on much larger scales, such as the organ,
full-body and even the population level; and vice-versa [1, 2]. We therefore
need to apply multiscale approaches when modelling many biomedical prob-
lems. Example biomedical multiscale challenges include predicting the impact
of a surgical procedure [3], investigating the effects of pathologies (e.g. arterial
malformations or fistulas [4]), or assessing the effects of a targeted drug on a
given patient [5]. In all these cases, we need to examine processes that not only
occur across several time and/or length scales, but that also rely on different
underlying physical and/or biological mechanisms. As a result, modelling these
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processes may require substantially different algorithms and varying levels of
computational effort.
Historically, these problems have often been modelled using single scale
approaches, focussing exclusively on those aspects of the problem which are
deemed most relevant. However, applying a single scale model is frequently
insufficient to fully understand the problem at hand, as additional processes
occurring on different scales must be incorporated to obtain sufficient accuracy.
It is this need for understanding the composite problem, rather than its indi-
vidual subcomponents alone, that has driven many research groups to explore
multiscale modelling; for example [6, 7, 8, 9].
In a multiscale model, the overall system is approximated by coupling two or
more single scale submodels. Establishing and performing the data exchange be-
tween these submodels is an important aspect of enabling multiscale modelling.
It is often addressed by using coupling tools, such as MUSCLE [10, 11], the
Multilevel Communicating Interface [12] and GridSpace [13]. Groen et al. [14]
provide a review of coupling tools and the computational challenges they ad-
dress.
Another important aspect is adopting a data standard which submodels
can adopt to exchange meaningful quantities. Several markup languages, such
as SBML [15] and CellML [16], resolve this problem by providing a descrip-
tion language for the storage and exchange of model data and submodel def-
initions. CellML specifically allows for submodel exchange between ODE and
PDE solvers, whereas SBML is aimed towards biochemical pathway and reaction
ODE submodels. Both SBML and CellML, being languages for the description
of submodels and system data, have serious limitations in that they require
additional tools to perform tasks that are not directly related to ensuring data
interoperability. These include transferring data between submodels, deploying
submodels on appropriate resources and orchestrating the interplay of submod-
els in a multiscale simulation. Additionally, they only provide very limited
features to describe submodels that do not rely on ODE-based methods, such
as finite-element/volume methods, spectral methods, lattice-Boltzmann, molec-
ular dynamics and particle-based methods, which are of increasing importance
in the biomedical domain.
Here we present a comprehensive approach to enable multiscale biomedi-
cal modelling from problem definition through the bridging of length and time
scales, to the deployment and execution of these models as multiscale simula-
tions. Our approach, which has been developed within the MAPPER project 1,
relies on coupling existing submodels and supports the use of resources rang-
ing from a local laptop to large international supercomputing infrastructures,
and distributed combinations of these. We present our approach for describing
multiscale biomedical models in section 2 and for constructing and executing
multiscale simulations on large computing infrastructures in section 3. We de-
scribe our approach for biomedical applications in section 4. We have applied
our approach to two biomedical multiscale applications, in-stent restenosis and
1http://www.mapper-project.eu/
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hierarchical cerebrovascular blood flow, which we present in sections 5 and 6
respectively. We conclude with a brief discussion.
2 Multiscale biomedical modelling
Multiscale modelling gives rise to a number of challenges which extend beyond
the translation of model and system data. Most importantly, we seek to allow
application developers, such as computational biologists and biomedics, to cou-
ple multiscale models for large problems, supporting any type of coupling, using
any type of submodel they wish to include, and executing this using any type of
computational resource, from laptop to petascale. Since we cannot expect com-
putational biologists to have expertise in all the technical details of multiscale
computing, we also aim to present a uniform and easy-to-use interface which
retains the power of the underlying technology. This also enables users with less
technical expertise to execute previously constructed multiscale simulations.
Multiscale systems are, in general, characterized by the interaction of phe-
nomena on different scales, but the details vary for different scientific domains.
To preserve the generality of our approach, we adopt the Multiscale Modelling
and Simulation Framework (MMSF) to reason about multiscale models in a
domain-independent context and to create recipes for constructing multiscale
simulations independent of the underlying implementations or computer archi-
tectures. This MMSF is based on earlier work on coupled cellular automata
and agent-based systems [17, 18] and has been applied to several computational
problems in biomedicine [19, 20, 3]. Within the MMSF, the interactions between
single-scale submodels are confined to well-defined couplings. The submodels
can therefore be studied as independent models with dependent incoming and
outgoing links. The graph of all submodels and couplings, the coupling topology,
can either be cyclic or acyclic [21]. In a cyclic coupling topology the submodels
will exchange information in an iterative loop, whereas in an acyclic topology the
submodels are activated one after another, resulting in a directional data flow
which makes them well-suited for workflow managers. Two parts of the MMSF
are particularly useful for our purposes, namely the Scale Separation Map [17]
and the Multiscale Modelling Language (MML) [22, 11]. The Scale Separa-
tion Map is a graphical representation which provides direct insights into the
coupling characteristics of the multiscale application. MML provides a formal-
ization of the coupling between the submodels, independent of the underlying
implementation. In addition, it simplifies the issues associated with orchestrat-
ing submodels by capturing the orchestration mechanisms in a simple model
which consists of only four distinct operators. MML definitions can be stored
for later use using an XML-based file format (xMML) or represented visually
using graphical MML (gMML) [11].
The generic MML definitions allow us to identify commonalities between
multiscale applications in different scientific domains. Additionally, the stored
xMML can be used as input for a range of supporting tools that facilitate mul-
tiscale simulations (e.g., tools that automate the deployment or the submodel
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coupling of these simulations, as discussed in section 3).
3 From multiscale model to production simula-
tion
We have developed a range of tools that allow us to create, deploy and run
multiscale simulations based on the xMML specification of a multiscale model.
Two of the main challenges in realising successful multiscale simulations are to
establish a fast and flexible coupling between submodels and to deploy and ex-
ecute the implementations of these submodels efficiently on computer resources
of any size. In this section we review these challenges and present our solutions
to them.
3.1 Coupling submodels
Effective and efficient coupling between submodels encompasses three major
aspects. First, we must translate our MML definitions to technical recipes for
the multiscale simulation execution. Second, we need to initiate and orchestrate
the execution of the submodels in an automated way, in accordance with the
MML specification. Third, we need to efficiently exchange model and system
information between the submodels.
The Multiscale Library and Coupling Environment (MUSCLE) [10, 11] pro-
vides a solution to the first two aspects. It uses MML in conjunction with a
definition of the requested resources to bootstrap and start the different sub-
models and to establish a connection for data exchange between the submodels.
It also implements the coupling definitions defined in the MMSF to orchestrate
the submodels. The submodels can be coupled either locally (on a workstation
for example), via a local network, or via a wide area network using the MUS-
CLE Transport Overlay (MTO) [23]. Running submodels in different locations
and coupling them over a wide area network is especially important when sub-
models have very different computational requirements, for example when one
submodel requires a local machine with a set of Python libraries, and another
submodel requires a large supercomputer. However, messages exchanged across
a wide area network do take longer to arrive. Among other things, MTO pro-
vides the means to exchange data between large supercomputers while adhering
to the local security policies and access restrictions.
The exchanges between submodels overlap with computations in many cases
(see section 6 for an example), allowing for an efficient execution of the overall
simulation. However, when the exchanges are particularly frequent or the ex-
changed data particularly large, inefficiencies in the data exchange can severely
slow down the multiscale simulation as a whole. We use the MPWide communi-
cation library [24], previously used to run cosmological simulations distributed
across supercomputers [25], to optimise our wide area communications for per-
formance. We already use MPWide directly within the cerebrovascular blood-
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flow simulation and are currently incorporating it in MUSCLE to optimise the
performance of the MTO.
3.2 Deploying and executing submodels on production re-
sources
When large multiscale models are deployed and executed as simulations on pro-
duction compute resources, a few major practical challenges arise. Production
resources are often shared by many users, and are difficult to use even partially
at appropriate times. This in turn makes it difficult to ensure that the sub-
models are invoked at the right times, and in cases where they are distributed
on different machines, to ensure that the multiscale simulation retains an ac-
ceptable time to completion. We use the QosCosGrid environment (QCG) [26]
to run submodels at a predetermined time on large computing resources. QCG
enables us, if installed on the target resource, to reserve these resources in ad-
vance for a given period of time to allow our submodels to be executed there.
This is valuable in applications that require cyclic coupling, as we then require
multiple submodels to be executed either concurrently or in alternating fashion.
Additionally, with QCG we can explicitly specifiy the sequence of resources to
be reserved, allowing us to repeat multiple simulations in a consistent manner
using the same resource sequence each time. A second component that aids in
the execution of submodels is the Application Hosting Environment (AHE) [27].
AHE simplifies user access to production resources by streamlining the authen-
tication methods and by centralising the installation and maintenance tasks of
application codes. The end users of AHE only need to work with one uniform
client interface to access and run their applications on a wide range of produc-
tion resources.
4 Using MAPPER for biomedical problems
We apply the MAPPER approach to a number of applications. We present two
of these applications here (in-stent restenosis and cerebrovascular blood flow),
but we have also used MAPPER to define, deploy and execute multiscale simu-
lations of clay-polymer nanocomposite materials [28], river beds and canals [29],
and several problems in nuclear fusion.
MAPPER provides formalisms, tools and services which aid in the descrip-
tion of multiscale models, as well as the construction, deployment and execu-
tion of multiscale simulations on production infrastructures. It is intended as a
general-purpose solution, and as such tackles challenges in multiscale simulation
that exist across scientific disciplines. There are a number of challenges which
are outside the scope of our approach, because they may require different solu-
tions for different scientific disciplines. These include choosing appropriate sub-
models for a multiscale simulation and defining, on the application level, what
information should be exchanged between submodels at which times to provide
a scientifically accurate and stable multiscale simulation. However, MMSF does
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simplify the latter task by providing a limited number of orchestration mech-
anisms. The formalisms, tools and services presented here are independent
components, allowing users to adopt those parts of our approach which specifi-
cally meet their requirements in multiscale modelling. This modular approach
makes it easier for users to exploit the functionalities of individual components
and helps to retain a lightweight simulation environment.
5 Modelling in-stent restenosis
Coronary heart disease (CHD) is one of the most common causes of death,
and is responsible for about 7.3 million deaths per year worldwide [30]. CHD
is typically expressed as artherosclerosis, which corresponds with a thickening
and hardening of blood vessels caused by build-up of atheromatous plaque;
when this significantly narrows the vessel, it is called a stenosis. A common
intervention for stenosis is stent-assisted balloon angioplasty where a balloon,
attached to a stent, is inserted in the blood vessel and inflated at the stenosed
location, consequently deploying the stent. The stent acts as a scaffold for the
blood vessel, compressing the plaque and holding the lumen open. Occasionally,
however, this intervention is followed by in-stent restenosis (ISR), an excessive
regrowth of tissue due to the injury caused by the stent deployment [31, 32].
Although there are a number of different hypotheses [33], the pathophysiological
mechanisms and risk factors of in-stent restenosis are not yet fully clear.
By modelling in-stent restenosis with a three-dimensional model (ISR3D) it
is possible to test mechanisms and risk factors that are likely to be the main
contributors to in-stent restenosis. After evaluating the processes involved in
in-stent restenosis [19], ISR3D applies the hypothesis that smooth muscle cell
proliferation drives the restenosis, and that this is affected most heavily by wall
shear stress of the blood flow, which regulates endothelium recovery, and by
growth inhibiting drugs diffused by a drug-eluting stent. Using the model we
can evaluate the effect of different drug intensities, physical stent designs, vas-
cular geometries and endothelium recovery rates. ISR3D is derived from the
two-dimensional ISR2D [20, 3] code. Compared to ISR2D it provides addi-
tional accuracy, incorporating a full stent design, realistic cell growth, and a
three-dimensional blood flow model, although it requires more computational
effort. We present several results from modelling a stented artery using ISR3D
in figure 2. This figure shows the artery both before and after restenosis has
occurred.
From a multiscale modelling perspective, ISR3D combines four submodels,
each operating on a different time scale: smooth muscle cell proliferation (SMC),
which models the cell cycle, cell growth, and physical forces between cells; initial
thrombus formation (ITF) due to the backflow of blood; drug diffusion (DD)
of the drug eluding stent through the tissue and applied to the smooth muscle
cells; and blood flow (BF) and the resulting wall shear stress on smooth muscle
cells. We show the time scales of each submodel and the relations between them
in figure 1. The SMC submodel uses an agent-based algorithm on the cellular
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Figure 1: Scale Separation Map of the ISR3D multiscale simulation, originally
presented in [11].
Figure 2: Images of a stented artery as modelled using ISR3D, before restenosis
occurs on the left and after 12.5 days of muscle cell proliferation on the right.
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scale, which undergoes validation on the tissue level. All other submodels act
on a cartesian grid representation of those cells. For the BF submodel we use
1,237,040 lattice sites, and for the SMC submodel we use 196,948 cells. The
exchanges between the submodels are in the order of 10 to 20 MB. The SMC
sends a list of cell locations and sizes (stored as 8-byte integers) to the ITF,
which sends the geometry (stored as a 3D matrix of 8-byte integers) to BF and
DD. In turn, BF and DD respectively send a list of wall shear stress and drug
concentrations (stored as 8-byte doubles) to SMC. Each coupling communication
between SMC and the other submodels takes place once per SMC iteration.
The submodels act independently, apart from exchanging messages, and are
heterogeneous. The SMC code is implemented in C++, the DD code in Java,
and the ITF code in Fortran. The BF code, which unlike the other codes runs in
parallel, uses the Palabos lattice-Boltzmann application2, written in C++. The
MML specification of ISR3D contains a few conversion modules not mentioned
above, which perform basic data transformations necessary to ensure that the
various single scale models do not need to be aware of other submodels and their
internal representation or scales. Specifically, the submodels operate within the
same domain, requiring the application to keep the grid and cell representation
consistent, as well as their dimensions.
5.1 Tests
We have performed a number of tests to measure both the runtime and the
efficiency of our multiscale ISR3D simulation. The runs that were performed
here were short versions of the actual simulations, with a limited number of
iterations. The runs constributed to the integration testing of the code and
allowed us to estimate the requirements for future computing resource proposals.
We have run our tests in five different scenarios, using the EGI resource in
Krakow (Zeus, one scenario), a Dutch PRACE tier-1 machine in Amsterdam
(Huygens, two scenarios), or a combination of both (two scenarios). We pro-
vide the technical specifications of the resources in table 1. Since the runtime
behaviour of ISR3D is cyclic, determined by the number of smooth muscle cell
iterations, we measured the runtime of a single cycle for each scenario. Because
only the BF model is parallelised, the resources we use are partially idle when-
ever we are not executing the BF model. To reduce this overhead of ‘idle time’,
we created two double mapping scenarios, each of which runs two simulations
in alternating fashion using the same resource reservation. In these cases, the
blood flow calculations of one simulation takes place while the other simulation
executes one or more of the other submodels. We use a wait/notify signalling
system within MUSCLE to enforce that only one of the two simulations in-
deed executes its parallel BF model. We have run one double mapping scenario
locally on Huygens, and one distributed over Huygens and Zeus.
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name processor freq. cores mem/node middleware
HECToR AMD Interlagos 2.3 GHz 512/2048 32 GB UNICORE
Huygens IBM Power6 4.7 GHz 32 128 GB UNICORE
Henry Intel Xeon 2.4 GHz 1 6 GB none
Zeus Intel Xeon 2.4 GHz 4 16 GB QCG-Comp.
Table 1: Computational characteristics of the machines we use in our multiscale
simulations for ISR3D and HemeLB. Clock frequency is given in the second
column, the number of cores used in the third column, and the amount of
memory per node in the fourth column. The administrative details are listed in
table 2.
name provider location infrastructure
HECToR EPCC Edinburgh, United Kingdom PRACE Tier-1
Huygens SARA Amsterdam, The Netherlands PRACE Tier-1
Henry UCL London, United Kingdom Local workstation
Zeus Cyfronet Krakow, Poland EGI (PL-Grid)
Table 2: Administrative information for the resources described in table 1.
5.1.1 Results
We present our performance measurements for the five scenarios in table 3. The
runtime of our simulation is reduced by almost 50% when we use the Huygens
machine instead of Zeus. This is because we run the BF code on Huygens using
32 cores, and on Zeus using 4 cores. However, the usage of the reservation was
considerably lower on Huygens than on Zeus for two reasons: first, the allocation
on Huygens was larger, leaving more cores idle when the sequential submodels
were computed; second, the ITF solver uses the gfortran compiler, which is not
2http://www.palabos.org/
scenario BF other coupling total usage %
Zeus 2100 1140 79 3240 80%
Huygens 480 1260 73 1813 27%
Huygens-double 480 1320 131 1931 45%
Zeus-Huygens 480 960 92 1532 32%
Zeus-Huygens-double 480 1080 244 1804 56%
Table 3: Runtimes with different scenarios. The name of the scenario is given in
the first column, the time spent on BF in the second, and the total time spent on
the other submodels in the third column (both rounded to the nearest minute).
We provide the coupling overhead in the fourth column and the total simulation
time per cycle in the fifth column. In the sixth column we provide the average
fraction of reserved resources doing computations (not idling) throughout the
period of execution. All time are given in seconds.
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well optimized for Huygens architecture. As a result it requires only 4 minutes
on Zeus and 12 minutes on Huygens. The performance of the other sequential
submodels is less platform dependent. When we run our simulation distributed
over both resources, we achieve the lowest runtime. This is because we combine
the fast execution of the BF module on Huygens with the fast execution of the
ITF solver on Zeus.
When we use double mapping, the runtime per simulation increases by about
6% (using only Huygens) to 18% (using both resources). However, the double-
mapping improves the usage of the reservation by a factor of ∼ 1.7. Double-
mapping is therefore an effective method to improve the resource usage without
incurring major increases to the time to completion of each simulation. The
coupling overhead is relatively low throughout our runs, consisting of no more
than 11% of the runtime throughout our measurements. Using our approach,
we are now modelling different in-stent restenosis scenarios, exploring a range
of modelling parameters.
5.2 Clinical directions
We primarily seek to understand which biological pathways dominate in the
process leading to in-stent restenosis. If successful, this will have two effects
on clinical practice: first, it suggests which factors are important for in-stent
restenosis, in turn giving clinicians more accurate estimates of what the progres-
sion of the disease can be; second, it may spur further directed clinical research
of certain pathways, which will help the next iteration of the model give more
accurate results.
The methods for achieving this divide naturally in two directions: general
model validation and experiments; and virtual patient cohort studies. For gen-
eral model validation we consult the literature and use basic experimental data,
such as measurements from animal studies. In addition, we intend to use vir-
tual patient cohort studies to assess the in-stent restenosis risk factors of virtual
patients with different characteristics. In clinical practice, this will not lead
to personalized estimates, but rather to patient classifiers on how ISR3D will
progress. Once the primary factors leading to in-stent restenosis have been
assessed, a simplified model could be made based on ISR3D, which takes less
computational effort and runs within a hospital.
6 Modelling of cerebrovascular blood flow
Our second hemodynamic example aims to incorporate not only the local arterial
structure in our models, but also properties of the circulation in the rest of the
human body. The key feature of this application is the multiscale modelling
of blood flow, delivering accuracy in the regions of direct scientific or clinical
interest while incorporating global blood flow properties using more approximate
methods. Here we provide an overview of our multiscale model and report on
its performance. A considerable amount of previous work has been done where
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groups combined bloodflow solvers of different types, for example in the area of
cardiovascular [34, 35, 36] or cerebrovascular bloodflow [37, 12].
We have constructed a distributed multiscale model in which we combine the
open source HemeLB lattice-Boltzmann application for blood flow modelling in
3D [38, 39] with the open source one-dimensional Python Navier-Stokes (pyNS)
blood flow solver [40]. HemeLB is optimized for sparse geometries such as
vascular networks, and has been shown to scale linearly up to at least 32,768
cores [41]. PyNS is a discontinuous Galerkin solver which is geared towards
modelling large arterial structures. It uses aortic blood flow input based on a
set of patient-specific parameters and it combines 1D wave propagation elements
to model arterial vasculature with 0D resistance elements to model veins. The
numerical code supports thread-level parallelization, and is written in Python
in conjunction with the numpy numerical library.
6.1 Simulations
We have run a number of coupled simulations using both HemeLB and pyNS
as submodels. Within pyNS we use a customised version of the ’Willis’ model,
based on [42], with a mean pressure 90 mmHg, a heart rate of 70 beats per
minute and a cardiac output of 5.68 litres per minute. Our model includes the
major arteries in the human torso, head and both arms, as well as a full model
for the circle of Willis, which is a major network of arteries in the human head.
For pyNS we use a time step size of 2.3766× 10−4 s.
We have modified a section of the right mid-cerebral artery (MCA) in pyNS
to allow it to be coupled to HemeLB in four places, exchanging pressure values
in these boundary regions. In HemeLB we simulate a small network of arteries,
with a voxel size of 3.5×10−5 m and consisting of about 4.2 million lattice sites
which occupy 2.3% of the simulation box volume. The HemeLB simulation
runs with a timestep of 2.3766× 10−6 s, a Mach number of 0.1 and a relaxation
parameter τ of 0.52. We run pyNS using a local machine at UCL (Henry),
while we run HemeLB for 400,000 time steps on the HECToR supercomputer
in Edinburgh. The round-trip time for a network message between these two
resources is on average 11 milliseconds. We provide technical details of both
machines in table 2. Both codes exchange pressure data at an interval of 100
HemeLB time steps (or 1 pyNS time step). Because HemeLB time steps can
take as little as 0.0002 seconds, we adopted MPWide to connect our submodels,
which run concurrently, and minimize the communication response time. The
exchanged data is represented using 8-byte doubles, and has a small aggregate
size (less than 1 kb). As a comparison, we have also run HemeLB as a standalone
single scale simulation (labelled ‘ss’), retrieving its boundary values from a local
configuration file. The pyNS code requires 116 seconds to simulate 4000 time
steps of our modified circle of Willis problem when run as a stand-alone code.
We present our results in table 4. For 512 cores, the single scale HemeLB
simulation takes 2271 seconds to perform its 400,000 lattice-Boltzmann time
steps. The coupled HemeLB-pyNS simulation is only marginally slower, reach-
ing completion in 2298 seconds. We measure a coupling overhead of only 24
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ss/ms cores Init HemeLB* coupling total coupling
t/s t/s t/s t/s efficiency
ss 512 47.9 2223 n/a 2271 n/a
ms 512 51.2 2223 24 2298 98.8%
ss 2048 46.4 815 n/a 862 n/a
ms 2048 50.5 815 37 907 95.0%
Table 4: Performance measurements of coupled simulations which consist of
HemeLB running on HECToR and pyNS running on a local UCL workstation.
The type of simulation, single scale (ss) or coupled multiscale (ms) is given in
the first colums. The number of cores used by HemeLB and the initialisation
time are respectively given in the second and third column. The time spent
on HemeLB and coupling work are given respectively in the fourth and fifth
column, the total time in the sixth column and the efficiency in the seventh
column. The times for HemeLB model execution in the multiscale runs are
estimates, which we derived directly from the single scale performance results
of the same problem on the same resources.
seconds, which is the time to do 4,002 pressure exchanges between HemeLB
and pyNS. This amounts to about 6 milliseconds per exchange, well below even
the round-trip time of the network between UCL and EPCC alone. The com-
munication time on the HemeLB side is so low because pyNS runs faster per
coupling iteration than HemeLB, and the incoming pressure values are already
waiting at the network interface when HemeLB begins to send out its own. As
a result, the coupling overhead is only 24 seconds, and the multiscale simulation
is only 1.2% slower than a single-scale simulation of the same network domain.
When using 2048 cores, the runtime for the single-scale HemeLB simulation
is 815 seconds, which is a speedup of 2.63 compared to the 512 core run. The
coupling overhead of the multiscale simulation is relatively higher than that of
the 512 core run due to a larger number of processes with which pressures must
be exchanged. This results in an overall coupling efficiency of 0.95, which is
lower than for the 512 core run. However, the 2048 core run contains ∼ 2000
sites per core, which is a regime where we no longer achieve linear scalability [41]
to begin with. As a future task, we plan to coalesce these pressure exchanges
with the other communications in HemeLB, using the coalesced communication
pattern [43].
6.2 Clinical directions
We aim to understand the flow dynamics in cerebrovascular networks and to
predict the flow dynamics in brain aneurysms for individual patients. The abil-
ity to predict the flow dynamics in cerebrovascular networks is of practical use
to clinicians, as it allows them to more accurately determine whether surgery
is required for a specific patient suffering from an aneurysm. In addition, our
work supports a range of other scenarios, which in turn may drive clinical in-
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vestigations of other vascular diseases.
Our current efforts focus on enhancing the model by introducing velocity ex-
change and testing our models for accuracy. As a first accuracy test we compared
different boundary conditions and flow models within HemeLB [39]. Addition-
ally we used our HemeLB-pyNS setup to compare different blood rheology mod-
els, which we describe in detail in [44]. Next steps include more patient-specific
studies, where we wish to compare the flow behavior within patient-specific net-
works of arteries in our multi-scale simulations with the measured from those
same patients. We have already established several key functionalities to allow
patient-specific modelling. For example, HemeLB is able to convert 3D rota-
tional angiographic data into initial conditions for the simulation, while pyNS
provides support for patient-specific global parameters and customized arterial
tree definitions.
7 Conclusions and Future Work
We have shown that MAPPER provides a usable and modular environment
which enables us to efficiently map multiscale simulation models to a range
of computing infrastructures. Our methods provide computational biologists
with the ability to more clearly reason about multiscale simulations, to for-
mally define their multiscale scenarios, and to more quickly simulate problems
that involve the use of multiple codes using a range of resources. We have pre-
sented two applications, in-stent restenosis and cerebrovascular bloodflow, and
conclude that both applications run rapidly and efficiently, even when using
multiple compute resources in different geographical locations.
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